Oglemilast

DRUG4 trials

Sponsors

Forest Laboratories, Glenmark Pharmaceuticals Europe Ltd. (R&D)

Conditions

AsthmaExercise-Induced AsthmaPulmonary Disease, Chronic Obstructive

Phase 2

Study of Oglemilast for the Prevention of Asthma.

CompletedNCT00322283

Forest LaboratoriesExercise-Induced Asthma

Start: 2006-05-31End: 2006-10-31Updated: 2012-04-10

Study of Oglemilast for the Treatment of Asthma

CompletedNCT00322686

Forest LaboratoriesAsthma

Start: 2006-05-31Updated: 2012-03-20

Study To Assess Efficacy and Safety of Oglemilast in Patients With Chronic Obstructive Pulmonary Disease (COPD)

CompletedNCT00671073

Forest LaboratoriesPulmonary Disease, Chronic Obstructive

Start: 2008-05-05End: 2009-05-15Updated: 2019-09-19

A Clinical Study of Oglemilast in Patients With Mild to Moderate Persistent Asthma

Glenmark Pharmaceuticals Europe Ltd. (R&D)Asthma

Start: 2008-10-31End: 2010-01-31Target: 282Updated: 2009-09-24